Daidzein Prevents Bone Loss in Ovariectomized Mice
Author Information
Author(s): Tyagi Abdul Malik, Srivastava Kamini, Sharan Kunal, Yadav Dinesh, Maurya Rakesh, Singh Divya
Primary Institution: Central Drug Research Institute (Council of Scientific and Industrial Research), Lucknow, India
Hypothesis
Does daidzein inhibit the increase in CD4+CD28null T cells and B lymphopoiesis in ovariectomized mice?
Conclusion
Daidzein helps prevent bone loss by reversing immune changes caused by estrogen deficiency.
Supporting Evidence
- Daidzein treatment reduced the expansion of CD4+ T cells in bone marrow and spleen.
- Daidzein decreased TNF-α levels in ovariectomized mice.
- Daidzein increased the percentage of CD4+CD28+ T cells in bone marrow.
- Daidzein inhibited the increase in B220+ B cells in bone marrow.
- Daidzein reduced osteoclastogenesis in co-culture with CD4+CD28null T cells.
Takeaway
Daidzein is a natural compound that can help protect bones in mice that have lost estrogen, which usually leads to bone loss.
Methodology
Adult Balb/c mice were treated with daidzein after ovariectomy, and various immune and bone parameters were analyzed after six weeks.
Potential Biases
Potential bias in the selection of treatment doses and the animal model used.
Limitations
The study was conducted only in mice, and results may not directly translate to humans.
Participant Demographics
Adult Balb/c mice, 9-10 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website